Pharmacogenomics and Opioid Use Disorder: Clinical Decision Support in an African American Cohort-Reference-Cited by-同舟云学术

Pharmacogenomics and Opioid Use Disorder: Clinical Decision Support in an African American Cohort

Published:2019-12 Issue:6 Volume:111 Page:674-681
ISSN:0027-9684
Container-title:Journal of the National Medical Association
language:en
Short-container-title:Journal of the National Medical Association

Author:

Ettienne Earl B.^ORCID,Ofoegbu Adaku^ORCID,Maneno Mary K.,Briggs Jayla,Ezeude Ginikannwa,Williams Simisola,Walker Casey,Chapman Edwin

Funder

Research Centers in Minority Institutions

Department of Healthcare Finance

National Institute on Minority Health and Health Disparities

National Institutes of Health

Publisher

Elsevier BV

Subject

General Medicine

Reference15 articles.

1. DSM-5 handbook of differential diagnosis;APA,2019

2. CDC. Understanding the epidemic | drug overdose | CDC injury center. Opioid Overdose 2018 2018-12-19T06:41:54Z [cited 2019 January 31]; Available from: https://www.cdc.gov/drugoverdose/epidemic/index.html.

3. Treatment of opioid-use disorders;Schuckit,2016

4. Treatments for substance use disorders,2016

5. WHO. Treatment of opioid dependence. WHO 2011 2011-02-08 15:04:15; Available from: http://www.who.int/substance_abuse/activities/treatment_opioid_dependence/en/.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Personalized medicine and opioid use disorder;World Journal of Psychiatry;2024-09-19

2. Opioid use disorder risk alleles in self-reported assigned African American/Afro-Caribbean and European biogeographical genetic ancestry groups and in males and females;The Pharmacogenomics Journal;2024-08

3. A Pharmacogenomics-Based In Silico Investigation of Opioid Prescribing in Post-operative Spine Pain Management and Personalized Therapy;Cellular and Molecular Neurobiology;2024-05-27

4. Gene Polymorphisms Playing Roles in Pharmacokinetics and Pharmacodynamics of Buprenorphine: An Overview;Bağımlılık Dergisi;2023-09-30

5. Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences;Acta Pharmaceutica;2023-06-01